Research published in the British Journal of Pharmacology suggests that biased agonists could maintain GLP-1 receptor efficacy over longer periods, potentially making resets unnecessary
Despite the promising findings summarized in this review, several limitations should be acknowledged
6.1 FA overload as a pathogenic catalyst Elevated levels of circulating FAs, derived predominantly from adipose lipolysis, DNL, and excessive dietary intake (238), represent the critical pathogenic drivers of GA
This research necessitates continued exploration, potentially revolutionizing future therapeutic strategies
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S -transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
doi:10.1016/0960-0760(92)90088-Z